Biogen NewsLatest News On Biogen Senior Clinical Data Manager - Ensuring Quality and Precision in Clinical Data Management7/14/2025 1:48 AM Clinical Operations Program Leader - Glomerular Disease at Biogen7/4/2025 1:47 AM Senior Medical Director for Alzheimer's Disease & Dementia Clinical Development6/4/2025 11:07 AM European regulators OK Alzheimer's treatment Leqembi after initial doubts4/16/2025 8:06 AM Biogen Surpasses Q4 Earnings Expectations with Leqembi Growth and Cost-Cutting Initiatives2/12/2025 7:10 AM Stocks @ Night: Meta's Winning Streak, Super Micro's Volatility, and More2/11/2025 8:48 PM Biogen to Acquire Sage Therapeutics for $7.22 per Share1/10/2025 7:13 PM European committee says Alzheimer's treatment Leqembi shouldn't get marketing approval7/26/2024 7:56 AM Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know6/10/2024 5:02 AM Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know6/10/2024 5:02 AM
